In a woman whose prior Pap smear was HPV‑positive but without ASCUS, and whose repeat Pap smear one year later shows ASCUS with a negative HPV test, what is the appropriate next step in management?

Management: Return to Routine Screening

For a woman with prior HPV-positive/cytology-negative result who now shows ASCUS with negative HPV, the appropriate next step is to return to routine screening intervals (every 3 years), NOT colposcopy. This represents a very low-risk scenario that does not warrant immediate colposcopic evaluation.

Risk Stratification

The key principle here is that HPV-negative ASCUS carries extremely low risk for high-grade disease:

• Women with HPV-negative ASCUS have only a 1.4% risk of developing CIN3+ over follow-up, compared to 15.2% in HPV-positive ASCUS patients 1
• This risk profile is essentially equivalent to women with completely negative cytology in the absence of HPV testing 1
• The negative predictive value for subsequent CIN3+ in HPV-negative ASCUS exceeds 99.7% 1

Guideline-Based Management Algorithm

According to the 2012 American Cancer Society/ASCCP/ASCP guidelines 2, the management pathway depends on the current test results, not the prior HPV-positive status:

Current Result: ASCUS + HPV Negative

• Action: Return to routine screening (3-year intervals for women 30-65 years)
• Rationale: The negative HPV test effectively "resets" the risk to baseline, regardless of prior HPV positivity

If Increased Surveillance is Chosen (Optional)

• Single HPV test at 12 months has significantly higher specificity (84%) than repeat cytology (71%) 1
• However, this is optional given the very low absolute risk

Why NOT Colposcopy?

Immediate colposcopy is not indicated because:

1. Risk threshold not met: The 2-year CIN3+ risk in HPV-negative ASCUS (1.4%) falls far below the 8-10% threshold used for colposcopy referral 2
2. Poor positive predictive value: Even with follow-up testing, the PPV for CIN3+ is only 2.6-3.8%, meaning 96-97% of colposcopies would be unnecessary 1
3. High false-positive rate: 53% of biopsies in HPV-negative ASCUS patients show no histological lesion 3

Common Pitfalls to Avoid

• Don't be misled by the prior HPV-positive result: The current HPV-negative status supersedes this finding in risk assessment
• Don't conflate this with HPV-positive ASCUS: That scenario (ASCUS + HPV positive) DOES require colposcopy, but this is the opposite situation
• Don't over-surveil: Excessive follow-up in this low-risk population leads to unnecessary procedures and patient anxiety without improving outcomes 1

Clinical Context

The prior HPV-positive result likely represented a transient infection that has cleared—this is the expected natural history for most HPV infections. The current ASCUS finding in the setting of HPV negativity represents reactive/inflammatory changes rather than true dysplasia, with an adjusted odds ratio for CIN2+ of only 0.47 compared to cytology-negative women 4.